广东东方昆仑(东莞)律师事务所 关于 惠州市锦好医疗科技股份有限公司 2025 年第四次临时股东会 之 法律意见书 广东东方昆仑(东莞)律师事务所 KUN LUN DONGGUAN LAW FIRM 二〇二六年一月 广东东方昆仑(东莞)律师事务所 关于 惠州市锦好医疗科技股份有限公司 2025 年第四次临时股东会 之 法律意见书 致:惠州市锦好医疗科技股份有限公司 广东东方昆仑(东莞)律师事务所(下称"本所")接受惠州市锦好医疗科 技股份有限公司(下称"公司")的委托,并根据《中华人民共和国公司法》(下 称"《公司法》"）、《中华人民共和国证券法》(下称"《证券法》")、《上 市公司股东会规则(2025年修订)》(下称"股东会规则")、《上市公司信 息披露管理办法》(下称"信息披露管理办法")等中华人民共和国(下称"中 国",为本法律意见书之目的,不包括香港特别行政区、澳门特别行政区和台湾 地区)的法律、行政法规、规章和规范性文件(下称"法律、法规、规范性文件") 以及现行有效的《惠州市锦好医疗科技股份有限公司章程》(下称"《公司章程》") 的有关规定,指派本所律师李丽丽律师、黄瑞平律师出席公司 2025年第 ...

证券代码：920925 证券简称：锦好医疗 公告编号：2026-001 惠州市锦好医疗科技股份有限公司 2025 年第四次临时股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 12 月 31 日 2.会议召开地点：公司会议室 3.会议召开方式：现场会议与网络投票相结合的方式召开 4.会议召集人：董事会 5.会议主持人：王敏先生 6.召开情况合法合规的说明： 2025 年 12 月 12 日，公司召开第三届董事会第十八次会议审议通过《关于 提请召开 2025 年第四次临时股东会的议案》，并于 2025 年 12 月 15 日在北京证 券交易所信息披露平台（http://www.bse.cn/）刊登了本次股东会的通知公告。本 次股东会的召集、召开、议案审议程序等符合《公司法》、《公司章程》及相关法 律法规的有关规定。 （二）会议出席情况 出席和授权出席本次股东会的股东共 5 人，持有表决权的股份总数 59,555,10 ...

Core Viewpoint - JinHao Medical (920925) experienced a significant decline of 14.57% in its stock price, with a trading volume turnover rate of 32.55% and a total transaction value of 597 million yuan, indicating high volatility in the market [2] Trading Activity Summary - The stock was listed on the North Exchange due to its turnover rate reaching 32.55%, with a total net sell of 47.16 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction value of 191 million yuan, with a buying amount of 71.88 million yuan and a selling amount of 119 million yuan, resulting in a net sell of 47.16 million yuan [2] - The largest buying brokerage was Dongfang Securities Co., Ltd. Shanghai Qingpu District Wuxie Bang Road Securities Business Department, with a buying amount of 25.89 million yuan, while the largest selling brokerage was CITIC Securities Co., Ltd. Beijing Branch, with a selling amount of 28.80 million yuan [2] Detailed Brokerage Activity - The top five buying brokerages and their respective amounts were: - 1st: Dongfang Securities, 25.89 million yuan - 2nd: Dongya Qianhai Securities, 16.18 million yuan - 3rd: Dongfang Caifu Securities, 9.22 million yuan - 4th: Dongfang Caifu Securities, 9.14 million yuan - 5th: Huatai Securities, 9.00 million yuan [2] - The top five selling brokerages and their respective amounts were: - 1st: CITIC Securities, 28.80 million yuan - 2nd: CITIC Jiantou Securities, 22.72 million yuan - 3rd: Dongfang Caifu Securities, 22.43 million yuan - 4th: GF Securities, 16.79 million yuan - 5th: Bohai Securities, 16.69 million yuan [2]

Core Viewpoint - On January 6, 2026, Jinhao Medical (920925) was featured on the trading leaderboard of the Beijing Stock Exchange due to a high turnover rate of 32.55%, with a trading volume of 17.9983 million shares and a transaction value of 597 million yuan [1][2]. Group 1 - Jinhao Medical's closing price on the trading day was 32.66 yuan [1]. - The top buying seat was from Dongfang Securities Co., Ltd., Shanghai Qianpu District, with a purchase amount of approximately 25.89 million yuan [1][2]. - The top selling seat was from CITIC Securities Co., Ltd., Beijing Branch, with a selling amount of approximately 28.80 million yuan [1][2]. Group 2 - The total transaction amount for Jinhao Medical on that day reached 597 million yuan [1]. - The trading volume was reported at 17.9983 million shares [1]. - The turnover rate of 32.55% indicates significant trading activity for the stock [1].

Market Overview - On January 5, the Shanghai Composite Index rose by 1.38%, with the total margin trading balance reaching 25,606.48 billion yuan, an increase of 199.66 billion yuan compared to the previous trading day [1] - The margin trading balance in the Shanghai market was 12,886.02 billion yuan, up by 86.86 billion yuan, while the Shenzhen market's balance was 12,639.08 billion yuan, increasing by 111.09 billion yuan [1] Industry Analysis - Among the industries tracked by Shenwan, 27 sectors saw an increase in margin trading balances, with the electronics sector leading, increasing by 33.50 billion yuan [1] - Other notable sectors included non-ferrous metals and machinery equipment, which saw increases of 25.87 billion yuan and 23.70 billion yuan, respectively [1] Stock Performance - A total of 2,310 stocks experienced an increase in margin trading balances, accounting for 61.34% of the market, with 537 stocks showing an increase of over 5% [1] - The stock with the highest increase in margin trading balance was Jinhao Medical, which saw a balance of 28.89 million yuan, up by 524.19% from the previous trading day, and its stock price rose by 20.03% [1] - Other significant performers included Henghe Co. and Zhite New Materials, with increases of 105.36% and 67.98% in margin trading balances, respectively [1] Top Gainers in Margin Trading - The top 20 stocks with the highest increase in margin trading balances averaged a rise of 7.48%, with Zhite New Materials, Jinhao Medical, and Xice Testing leading with increases of 20.04%, 20.03%, and 20.00%, respectively [2] Decliners in Margin Trading - In contrast, 1,456 stocks saw a decrease in margin trading balances, with 178 stocks declining by more than 5% [4] - The stock with the largest decrease was Cuiwei Co., with a margin trading balance of 30.6 million yuan, down by 30.18% [5] - Other notable decliners included Southern Pump Industry and Tianming Technology, with decreases of 23.67% and 23.22%, respectively [4]

Group 1 - The core stock price of JinHao Medical (920925) closed at 38.23 yuan on January 5, 2026, with an increase of 20.03% and a turnover rate of 19.58%, resulting in a trading volume of 108,300 lots and a transaction amount of 394 million yuan [1] - On January 5, the net inflow of main funds was 84.54 million yuan, accounting for 21.44% of the total transaction amount, while retail investors had a net inflow of 1.80 million yuan, representing 0.46% of the total transaction amount [2][4] - JinHao Medical was listed among the top 5 stocks on the Dragon and Tiger List due to its closing price increase of 20% on January 5, marking its first appearance on the list in the past 5 trading days [3][4]

Group 1 - The stock of JinHao Medical (920925) increased by 20.03% today, with a turnover rate of 19.58% and a total transaction amount of 394 million yuan, showing a volatility of 29.18% [1] - The stock was listed on the exchange due to its daily price fluctuation reaching 20.03%, with a total net selling amount of 16.5892 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction of 120 million yuan, with a buying amount of 51.5093 million yuan and a selling amount of 68.0984 million yuan, resulting in a net selling of 16.5892 million yuan [2] Group 2 - The largest buying brokerage was Huatai Securities Co., Ltd. Shenzhen Qianhai Securities, with a buying amount of 13.12 million yuan, while the largest selling brokerage was Debon Securities Co., Ltd. Shanghai Zhengli Road Securities, with a selling amount of 15.5407 million yuan [2] - Detailed trading information shows that the top five buying brokerages had no selling amounts, while the top five selling brokerages had significant selling amounts, indicating a strong selling pressure [2]

Summary of Key Points Core Viewpoint The trading volume and value of stocks on the Beijing Stock Exchange (BSE) showed a significant increase on January 5, with a total trading volume of 803 million shares and a total trading value of 21.188 billion yuan, marking an increase of 474 million yuan compared to the previous trading day. The majority of stocks experienced price increases, indicating a positive market sentiment. Trading Performance - The total trading volume on the BSE reached 803 million shares, with a trading value of 21.188 billion yuan, an increase of 474 million yuan from the previous day [1] - A total of 226 stocks closed higher, accounting for 79.02% of the tradable stocks, with notable gainers including KaiDe Quartz (up 22.36%), JinHao Medical (up 20.03%), and HengDong Light (up 12.94%) [1] - Conversely, 57 stocks closed lower, with TianMing Technology, JiaXian Co., and LiFang Holdings experiencing the largest declines of 15.03%, 10.33%, and 8.46% respectively [1] Active Stocks - 56 stocks had a trading value exceeding 100 million yuan, with HengDong Light leading at 1.909 billion yuan, followed by XingTu Measurement Control at 736 million yuan and KaiDe Quartz at 477 million yuan [1] - The trading activity was robust, with 23 stocks having a turnover rate exceeding 10%, and 5 stocks exceeding 20% [1] - The stocks with the highest turnover rates included DaPeng Industrial (28.25%), HengDong Light (27.83%), and ChenGuang Medical (24.13%) [1] Notable Stock Data - The closing prices and performance of key stocks included: - HengDong Light: 348.99 yuan, up 12.94%, turnover rate 27.83%, trading value 1.909 billion yuan [1] - XingTu Measurement Control: 90.50 yuan, up 7.10%, turnover rate 19.74%, trading value 736 million yuan [1] - KaiDe Quartz: 47.28 yuan, up 22.36%, turnover rate 18.24%, trading value 477 million yuan [1]

Group 1 - The core point of the article is that JinHao Medical (stock code: 920925) experienced a significant price increase of 20.03% on January 5, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" [1][3] - The trading volume for JinHao Medical on that day reached 10.8265 million shares, with a total transaction value of 394 million yuan [1][2] - The top buying position was held by Huatai Securities Co., Ltd. with a purchase amount of approximately 13.12 million yuan, while the top selling position was held by Debon Securities Co., Ltd. with a selling amount of approximately 15.54 million yuan [1][2] Group 2 - The article provides detailed trading data, including the top five buying and selling brokerage firms, highlighting significant transactions from various securities companies [2] - Notably, the second-largest buying position was from China Galaxy Securities with approximately 11.51 million yuan, and the third from Dongfang Securities with about 10.48 million yuan [2] - On the selling side, the second-largest selling position was from Guosen Securities with approximately 15.24 million yuan, indicating a competitive trading environment [2]

Group 1 - The medical device sector experienced a significant increase of 5.5% on January 5, with JinHao Medical leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] - Notable individual stock performances included JinHao Medical with a closing price of 38.23, up 20.03%, and BoTuo Bio with a closing price of 45.34, also up 20.01% [1] Group 2 - The medical device sector saw a net inflow of 1.678 billion yuan from institutional investors, while retail investors experienced a net outflow of 644 million yuan [2] - The top individual stock in terms of net inflow was AiPeng Medical, with a net inflow of 1.57 million yuan, representing 25.59% of its trading volume [3] - Conversely, major outflows were observed in stocks like MaiRui Medical, which had a net outflow of 91.39 million yuan from retail investors, accounting for 2.74% of its trading volume [3]